Literature DB >> 24472191

Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.

J M Zimmerer1, T A Pham, C L Wright, K J Tobin, P B Sanghavi, S M Elzein, V M Sanders, G L Bumgardner.   

Abstract

While it is well known that CD4(+) T cells and B cells collaborate for antibody production, our group previously reported that CD8(+) T cells down-regulate alloantibody responses following transplantation. However, the exact mechanism involved in CD8(+) T cell-mediated down-regulation of alloantibody remains unclear. We also reported that alloantibody production is enhanced when either perforin or FasL is deficient in transplant recipients. Here, we report that CD8(+) T cell-deficient transplant recipient mice (high alloantibody producers) exhibit an increased number of primed B cells compared to WT transplant recipients. Furthermore, CD8(+) T cells require FasL, perforin and allospecificity to down-regulate posttransplant alloantibody production. In vivo CD8-mediated clearance of alloprimed B cells was also FasL- and perforin-dependent. In vitro data demonstrated that recipient CD8(+) T cells directly induce apoptosis of alloprimed IgG1(+) B cells in co-culture in an allospecific and MHC class I-dependent fashion. Altogether these data are consistent with the interpretation that CD8(+) T cells down-regulate posttransplant alloantibody production by FasL- and perforin-dependent direct elimination of alloprimed IgG1(+) B cells. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Alloantibody; B cells; CD8+ T cells; FasL; Perforin

Mesh:

Substances:

Year:  2014        PMID: 24472191      PMCID: PMC4018729          DOI: 10.1111/ajt.12565

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  75 in total

1.  Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable.

Authors:  David Hassin; Orit G Garber; Avihai Meiraz; Yael S Schiffenbauer; Gideon Berke
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

2.  Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.

Authors:  Jianping Yang; Stephanie P Huck; Rebecca S McHugh; Ian F Hermans; Franca Ronchese
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

Review 3.  Pathological features of antibody-mediated rejection.

Authors:  Akira Shimizu; Robert B Colvin
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2005-06

4.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division.

Authors:  S Oehen; K Brduscha-Riem
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

5.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.

Authors:  J Strehlau; M Pavlakis; M Lipman; M Shapiro; L Vasconcellos; W Harmon; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.

Authors:  G L Bumgardner; D Gao; J Li; J H Baskin; M Heininger; C G Orosz
Journal:  Transplantation       Date:  2000-12-27       Impact factor: 4.939

7.  Dendritic cells internalise and re-present conformationally intact soluble MHC class I alloantigen for generation of alloantibody.

Authors:  Allison J Curry; Gavin J Pettigrew; Margaret C Negus; Alistair J Easterfield; Joyce L Young; Eleanor M Bolton; J Andrew Bradley
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

8.  Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection.

Authors:  Dongmei Han; Xiumin Xu; David Baidal; Jenifer Leith; Camillo Ricordi; Rodolfo Alejandro; Norma S Kenyon
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

9.  Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort.

Authors:  Matthias Lorenz; Heinz Regele; Martin Schillinger; Markus Exner; Susanne Rasoul-Rockenschaub; Markus Wahrmann; Josef Kletzmayr; Gerd Silberhumer; Walter H Hörl; Georg A Böhmig
Journal:  Transplantation       Date:  2004-08-15       Impact factor: 4.939

10.  Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo.

Authors:  Avihai Meiraz; Orit Gal Garber; Shaul Harari; David Hassin; Gideon Berke
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

View more
  15 in total

1.  Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.

Authors:  Naoki Kohei; Toshiaki Tanaka; Kazunari Tanabe; Naoya Masumori; Nina Dvorina; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2016-04-28       Impact factor: 10.612

Review 2.  Immunological aspects of liver cell transplantation.

Authors:  Felix Oldhafer; Michael Bock; Christine S Falk; Florian W R Vondran
Journal:  World J Transplant       Date:  2016-03-24

3.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

4.  mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.

Authors:  Christina L Avila; Jason M Zimmerer; Steven M Elzein; Thomas A Pham; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939

5.  Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.

Authors:  Jason M Zimmerer; Phillip H Horne; Mason G Fisher; Thomas A Pham; Keri E Lunsford; Bryce A Ringwald; Christina L Avila; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939

Review 6.  Experimental modeling of desensitization: What have we learned about preventing AMR?

Authors:  Jean Kwun; Stuart Knechtle
Journal:  Am J Transplant       Date:  2020-06       Impact factor: 8.086

7.  Critical role of NKT cells in posttransplant alloantibody production.

Authors:  J M Zimmerer; P Swamy; P B Sanghavi; C L Wright; M Abdel-Rasoul; S M Elzein; R R Brutkiewicz; G L Bumgardner
Journal:  Am J Transplant       Date:  2014-09-12       Impact factor: 8.086

8.  Antibody-suppressor CXCR5+ CD8+ T cellular therapy ameliorates antibody-mediated rejection following kidney transplant in CCR5 KO mice.

Authors:  Jason M Zimmerer; Jing L Han; Chelsea M Peterson; Qiang Zeng; Bryce A Ringwald; Clarissa Cassol; Sachi Chaudhari; Madison Hart; Jessica Hemminger; Anjali Satoskar; Mahmoud Abdel-Rasoul; Jiao-Jing Wang; Robert T Warren; Zheng J Zhang; Christopher K Breuer; Ginny L Bumgardner
Journal:  Am J Transplant       Date:  2022-02-15       Impact factor: 9.369

9.  Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+ T Cells With De Novo DSA Production in the First Year After Kidney Transplant.

Authors:  Jason M Zimmerer; Matthew W Basinger; Bryce A Ringwald; Mahmoud Abdel-Rasoul; Ronald P Pelletier; Amer Rajab; Ashraf El-Hinnawi; Hemant Parekh; Kenneth Washburn; Ginny L Bumgardner
Journal:  Transplantation       Date:  2020-11       Impact factor: 5.385

Review 10.  CXCR5+CD8+ T cells: A Review of their Antibody Regulatory Functions and Clinical Correlations.

Authors:  Steven M Elzein; Jason M Zimmerer; Jing L Han; Bryce A Ringwald; Ginny L Bumgardner
Journal:  J Immunol       Date:  2021-06-15       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.